Top Buy
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Insulet Corp. | 47 | 0 | 17 | 0 | €261.60 | €315.97 | 20.784% |
| Eli Lilly Corp. | 44 | 1 | 15 | 0 | €867.40 | €933.08 | 7.573% |
| Medtronic plc | 24 | 1 | 7 | 0 | €87.04 | €89.07 | 2.334% |
| Amgen Inc. | 25 | 4 | 7 | 0 | €283.30 | €296.66 | 4.716% |
| Arrowhead Pharmaceuticals Inc. | 19 | 0 | 6 | 0 | €52.76 | €64.41 | 22.087% |
| Agios Pharmaceuticals Inc. | 11 | 1 | 6 | 0 | €24.00 | €43.63 | 81.773% |
| Agilent Technologies Inc. | 23 | 0 | 6 | 0 | €124.90 | €140.88 | 12.791% |
| MannKind Corp. | 24 | 0 | 6 | 0 | €4.88 | €8.60 | 76.060% |
| AnaptysBio Inc | 24 | 0 | 5 | 0 | €36.60 | €44.30 | 21.048% |
| Personalis Inc | 21 | 0 | 5 | 0 | €9.01 | €10.39 | 15.336% |
| Vertex Pharmaceuticals Inc. | 43 | 0 | 5 | 0 | €391.10 | €468.71 | 19.843% |
| Jazz Pharmaceuticals plc | 39 | 0 | 5 | 0 | €145.80 | €170.70 | 17.075% |
| Gilead Sciences Inc | 36 | 0 | 4 | 0 | €104.12 | €117.11 | 12.481% |
| Dexcom Inc. | 37 | 0 | 4 | 0 | €56.26 | €82.41 | 46.485% |
| Charles River Labs Intl | 19 | 0 | 4 | 0 | €158.25 | €165.88 | 4.819% |
| AbbVie Inc. | 37 | 0 | 4 | 0 | €194.20 | €209.13 | 7.688% |
| Insmed Inc. | 53 | 0 | 4 | 0 | €174.00 | €167.19 | -3.915% |
| Xencor Inc. | 15 | 2 | 4 | 0 | €15.30 | €22.87 | 49.490% |
| Alkermes plc | 17 | 0 | 4 | 0 | €25.00 | €38.70 | 54.809% |
| Regeneron Pharmaceuticals Inc. | 37 | 2 | 4 | 0 | €616.80 | €705.36 | 14.358% |
| Stryker Corp. | 27 | 0 | 4 | 0 | €312.50 | €407.30 | 30.337% |
| Acadia Pharmaceuticals | 27 | 1 | 4 | 0 | €23.57 | €27.38 | 16.161% |
| Tenet Healthcare | 40 | 0 | 3 | 0 | €181.00 | €181.10 | 0.055% |
| Idexx Laboratories Inc. | 15 | 0 | 3 | 0 | €613.20 | €673.40 | 9.817% |
| Bio-Techne Corp. | 17 | 0 | 3 | 0 | €53.00 | €60.82 | 14.760% |